Jesse Nevarez

Jesse Nevarez is a partner in the firm’s Business Law Department and a member of its Technology and Life Sciences groups.

Mr. Nevarez’s practice centers on representing technology and life sciences companies focused on digital media, software, food delivery, advertising, biotechnology, pharmaceuticals, medical devices, diagnostics and other related specialties. In particular, he regularly advises entrepreneurs, startups, emerging companies and public companies on a variety of matters including company formations, seed, venture and growth equity financings, mergers and acquisitions, SEC compliance, IPOs, and other capital markets transactions. He also represents venture capital funds and investment banks focusing on technology and life sciences companies.

Mr. Nevarez has been named to the Lawyers of Color “Hot List” and named a Massachusetts Super Lawyer “Rising Star”.

Mr. Nevarez is a member of the Boston Bar Association, the Massachusetts Black Lawyers Association, the New York State Bar Association and the American Bar Association. He is also a member of the Boston College Law School Black Alumni Network and has served as a mentor for the MIT $100K Launch Competition.

Mr. Nevarez joined Goodwin in 2013.  Prior to joining Goodwin, he was an associate at Choate, Hall & Stewart LLP.

A selection of Mr. Nevarez’s recent public offerings include:

• Ascentage Pharma Group International in its $61 million initial public offering
• Sage Therapeutics, Inc. in its $103.5 million initial public offering and several follow-on public offerings raising an aggregate of $2.07 billion
• Neon Therapeutics, Inc. in its $100 million initial public offering
• Magenta Therapeutics, Inc. in its $100 million initial public offering
• TPI Composites, Inc. in its $79 million initial public offering
• Plug Power Inc. in follow-on offerings raising an aggregate of $146.8 million

A selection of Mr. Nevarez’s recent mergers and acquisitions include:

• Open Lending, LLC in its business combination with Nebula Acquisition Corporation, a publicly-traded special purpose acquisition company
• TripAdvisor in its acquisition of Viator
• TAG Manufacturing in its acquisition by Center Rock Capital Partners
• Neon Therapeutics, Inc. in its acquisition by BioNTech
• Lysosomal Therapeutics, Inc. in its exclusive option agreement with Allergan plc

A selection of Mr. Nevarez’s recent venture financings include:

• Freshly Inc. in its Series B, Series C and Series C-1 financings
• CMDTY Inc. in its Series A financing
• Podium Data, Inc. in its Series Seed and Series A financings
• Yumanity Therapeutics in its Series A, Series B and Series C financings
• Enspire DBS Therapy in its Series A financing